Register / Fatty acid
Omega-3 (DHA and EPA)
4 authorised claims · NRV 250 mg DHA + EPA
What the regulation allows
- “Omega-3 DHA contributes to the maintenance of normal brain function”
- “Omega-3 DHA contributes to the maintenance of normal vision”
- “Omega-3 EPA and DHA contribute to the normal function of the heart”
- “Omega-3 DHA and EPA contribute to the maintenance of normal blood triglyceride levels”
Dose condition
heart: at least a source of EPA+DHA (15% of the 250 mg NRV, i.e. 37.5 mg per daily portion), with a statement that the benefit is obtained at 250 mg/day. brain and vision: at least 40 mg of DHA per 100 g AND per 100 kcal, with a statement that the benefit is obtained at 250 mg DHA/day
Reg. 432/2012, Annex. 'DHA contributes to maintenance of normal brain function' and '…normal vision' may be used only for food containing at least 40 mg of DHA per 100 g and per 100 kcal. That is a density test, not a per-portion test: at roughly 330 kcal per 100 g a gummy needs about 3 mg of DHA per piece to clear the 100 kcal limb, but the pack must still tell the consumer that 250 mg/day is what the evidence used.
Wording that fails
| Phrase | Why it fails |
|---|---|
| “Omega-3 prevents heart attack” | Reads as a disease claim, which needs an Article 14 authorisation. |
| “Omega-3 improves memory” | Claims an effect beyond maintenance of normal function. |
| “Omega-3 reduces inflammation” | Not among the authorised wordings for this substance. |
In a gummy
3 mg of DHA is easy; 250 mg is not. 250 mg of oil in a 2.5 g piece is 10% of the piece weight and it softens the matrix, then oxidises into a fishy note. So a gummy can carry the brain claim on a dose that does nothing, which is legal and commercially awkward. Emulsified or powdered algal DHA is the usual route at 20–50 mg.
Marketing phrases that touch this substance
| Phrase | Verdict | Authorised alternative |
|---|---|---|
| Supports heart health | Conditional | EPA and DHA contribute to the normal function of the heart |